$14.29
+0.03
(+0.21%)▲
0.21%
Downside
Day's Volatility :0.21%
Upside
0.0%
37.93%
Downside
52 Weeks Volatility :41.34%
Upside
5.49%
Period | R1 Rcm Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 2.22% | -2.1% | 0.0% |
6 Months | 11.76% | 4.9% | 0.0% |
1 Year | 33.4% | 16.0% | 0.0% |
3 Years | -44.12% | 10.0% | -26.4% |
Market Capitalization | 6.0B |
Book Value | $6.69 |
Earnings Per Share (EPS) | -0.09 |
PEG Ratio | 1.08 |
Wall Street Target Price | 14.52 |
Profit Margin | -1.68% |
Operating Margin TTM | 8.81% |
Return On Assets TTM | 2.9% |
Return On Equity TTM | -1.44% |
Revenue TTM | 2.4B |
Revenue Per Share TTM | 5.67 |
Quarterly Revenue Growth YOY | 12.0% |
Gross Profit TTM | 361.3M |
EBITDA | 554.6M |
Diluted Eps TTM | -0.09 |
Quarterly Earnings Growth YOY | -0.99 |
EPS Estimate Current Year | -0.21 |
EPS Estimate Next Year | 0.22 |
EPS Estimate Current Quarter | -0.05 |
EPS Estimate Next Quarter | -0.05 |
What analysts predicted
Upside of 1.61%
Sell
Neutral
Buy
R1 Rcm Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
R1 Rcm Inc | 0.49% | 11.76% | 33.4% | -44.12% | 29.64% |
Solventum Corp | 6.97% | 12.01% | 4.86% | 4.86% | 4.86% |
Tempus Ai | -13.0% | 14.43% | 14.43% | 14.43% | 14.43% |
Veeva Systems Inc. | 3.96% | 4.75% | 8.48% | -33.51% | 46.51% |
Ge Healthcare Technologies Inc. | -4.89% | 8.96% | 22.31% | 43.74% | 43.74% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
R1 Rcm Inc | 1152.8 | NA | 1.08 | -0.21 | -0.01 | 0.03 | NA | 6.69 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Tempus Ai | NA | NA | NA | -2.41 | 0.0 | 0.0 | NA | 0.64 |
Veeva Systems Inc. | 56.89 | 56.89 | 1.22 | 4.76 | 0.13 | 0.06 | NA | 32.04 |
Ge Healthcare Technologies Inc. | 23.93 | 23.93 | 2.29 | 4.28 | 0.22 | 0.06 | 0.0 | 18.2 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
R1 Rcm Inc | Buy | $6.0B | 29.64% | 1152.8 | -1.68% |
Solventum Corp | Hold | $10.8B | 4.86% | NA | 15.73% |
Tempus Ai | NA | $7.9B | 14.43% | NA | -121.04% |
Veeva Systems Inc. | Buy | $34.5B | 46.51% | 56.89 | 23.91% |
Ge Healthcare Technologies Inc. | Buy | $39.9B | 43.74% | 23.93 | 8.56% |
Insights on R1 Rcm Inc
Revenue is up for the last 10 quarters, 385.7M → 627.9M (in $), with an average increase of 5.1% per quarter
Netprofit is up for the last 2 quarters, -35.1M → -7.6M (in $), with an average increase of 361.8% per quarter
New Mountain Capital, L.L.C.
BlackRock Inc
Vanguard Group Inc
Coliseum Capital Management LLC
Voss Capital LLC
Hawk Ridge Management LLC
R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.
Organization | R1 Rcm Inc |
Employees | 29400 |
CEO | Mr. Lee Rivas |
Industry | Health Services |